Genomic Instability based analysis of drugable targets in Head and Neck Cancer: Tumor tissue for an ex vivo pilot study

Genomic Instability based analysis of drugable targets in Head and Neck Cancer: Tumor tissue for an ex vivo pilot study - GIBADT-HNC: ex vivo pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47568

Enrollment

Registered

2015-06-15

Start date

2015-09-07

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer HNSCC

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Strong suspicion of or proven carcinoma of the oral cavity, pharynx or larynx. - > 18 yrs of age - Planned routine biopsy or planned surgical resection as part of standard diagnostic work-up or treatment - expected tumor volume > 2 cm3 - informed consent

Exclusion criteria

Exclusion criteria: - non-squamous cell carcinoma after definitive histological analysis

Design outcomes

Primary

Measure	Time frame
viable tumor tissue after 6 days ex vivo culturing	—

Countries

Netherlands

Outcome results